Contract manufacturing is an increasing part of the pharmaceutical business. In cell therapy this need is magnified because of the demand for cell and gene therapy products. Kalorama Information’s report the Market for Cell and Gene Therapy Contract Manufacturing Organizations (CMOs) details the following:
Biopharmaceutical Contract Manufacturing Market
Role
Services Offered
Usage Drivers
Profiles of Companies, Key Players, and Competitors in the Market
COVID-19’s Challenges and Opportunities for CMOs
Global and Regional Market Overviews—U.S., Europe, and Other Nations
New Developments and Advancing Technology
Development pipeline
Production Issues
Cost
Logistics
Mergers and Acquisitions
Page Count: 134
Table of Contents
Chapter 1: Executive Summary
Overview
Scope and Methodology
COVID-19
Market Overview and Potential
Cell and Gene Therapy Market
BCMO Market
Cell and Gene Therapy BCMO Market
Chapter 2: Introduction to Cell and Gene Therapy
Introduction
Cell Therapy
Gene Therapy
Viral Vector System and New Developments
Non-viral Systems for Transporting Genes
End Users
Hospitals
Research Institutes
Wound Care Centers
Cancer Centers
Chapter 3: Cell and Gene Therapy Industry - Product Pipeline, Production & Key Players
Overview
Regulatory Pathway
Priority Review
Accelerated Approval
Fast Track
Breakthrough Therapy
Orphan Drug
Individualized Gene Therapy Approval Process
Development Pipeline
Production Issues
Differences from Biologics Manufacturing
Manufacturing Process for CAR-T
Advancements and Barriers in Manufacturing Processes
What is the Size of IVD Market Segments? Who’s Winning? Who’s Merged? Who’s Launched Game-Changing Products?
One book definitively answers these questions, from a publisher that is focused on in vitro diagnostics. Now in its 13th edition, this…
